Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
Balar, A.V., Castellano, D.E., Grivas, P., Vaughn, D.J., Powles, T., Vuky, J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N.J., Climent, M.A., Necchi, A., Petrylak, D.P., Plimack, E.R., Xu, J.Z., Imai, K., Moreno, B.H., Bellmunt, J., de Wit, R., O’Donnell, P.H.
Published in Annals of oncology (01.03.2023)
Published in Annals of oncology (01.03.2023)
Get full text
Journal Article
The Initial Report of RTOG 0524: Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Pham, H.T, Hu, C, Michaelson, M.D, Dahl, D.M, Wu, C, Whittington, R.M, Swanson, G.P, Vuky, J, Lee, R.J, Souhami, L, Chang, B.K, George, A, Sandler, H.M, Shipley, W
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Published in International journal of radiation oncology, biology, physics (01.09.2014)
Get full text
Journal Article
Phase I Trial of 40-kd Branched Pegylated Interferon Alfa-2a for Patients With Advanced Renal Cell Carcinoma
MOTZER, Robert J, RAKHIT, Ashok, GINSBERG, Michelle, RITTWEGER, Karen, VUKY, Jacqueline, YU, Richard, FETTNER, Scott, HOOFTMAN, Leon
Published in Journal of clinical oncology (01.03.2001)
Published in Journal of clinical oncology (01.03.2001)
Get full text
Journal Article
591P A first-in-human study of FOR46 in men with metastatic castration resistant prostate cancer (mCRPC)
Aggarwal, R.R., Vuky, J., VanderWeele, D., Rettig, M., Heath, E., Nasoff, M., Dorr, A., Liu, B., Small, E.J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
MA15.09 Ph 2 Trial of IO102-IO103 Vaccine Plus Pembrolizumab: Preliminary Results for the First-line Treatment of Lung Adenocarcinoma
Riess, J.W., Cohen, E., Vuky, J., Shaw, P., Rubio, J., Rodriguez, L.M., Chaney, M.F., O'Neill, S., Alavi, A., McDowell, D.O., Ehrnrooth, E., Garrido, P.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
1813P Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results
Laccetti, A.L., Chatta, G., Kyriakopoulos, C., Iannotti, N., Hotte, S.J., Markowski, M.C., Pili, R., Vuky, J., Zhang, J., Saad, F., Villaluna, K., Younginger, B., Le Moigne, R., Cesano, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1752P Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011
Loriot, Y., Csoszi, T., Matsubara, N., Shin, S.J., Park, S.H., Atduev, V., Gumus, M., Karaca, B.B., Grivas, P., De Wit, R., Siefker-Radtke, A.O., Castellano Gauna, D.E., O'Donnell, P.H., Powles, T.B., Vuky, J., Zhao, Y., O'hara, K., Franco, S., Homet Moreno, B., Zolnierek, J.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Pembrolizumab produces clinically meaningful responses as first-line therapy in cisplatin-ineligible advanced urothelial cancer: Results from subgroup analyses of KEYNOTE-052
Powles, T, Bellmunt, J, Castellano, D, O’Donnell, P, Grivas, P, Vuky, J, Plimack, E, Hahn, N, Balar, A, Pang, L, Savage, M, Perini, R, Keefe, S, Bajorin, D, De Wit, R
Published in European urology supplements : official journal of the European Association of Urology (01.03.2017)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2017)
Get full text
Journal Article
Pembrolizumab (pembro) as first-line therapy for advanced/unresectable or metastatic urothelial cancer: Preliminary results from the phase 2 KEYNOTE-052 study
Balar, A., Bellmunt, J., O'Donnell, P.H., Castellano, D., Grivas, P., Vuky, J., Powles, T., Plimack, E.R., Hahn, N.M., de Wit, R., Pang, L., Savage, M.J., Perini, R., Keefe, S., Bajorin, D.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
744P Association between gene expression signatures (sigs) and pembrolizumab (pembro) efficacy in patients (pts) with advanced urothelial cancer (UC)
Grivas, P., Balar, A.V., Vuky, J., de Wit, R., Vogelzang, N.J., Choueiri, T.K., Bajorin, D., Castellano Gauna, D., Gerritsen, W., Gurney, H., Quinn, D.I., Culine, S., Fradet, Y., Saadatpour, A., Loboda, A., Ma, J., Rajasagi, M., Godwin, J.L., Moreno, B.H., Bellmunt, J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
VOLGA: Results from the phase 3 safety run-in with durvalumab (D) + tremelimumab (T) + enfortumab vedotin (EV) for cisplatin-ineligible muscle-invasive bladder cancer (MIBC)
Powles, T., Bupathi, M, Joshi, M., Fleming, M., Gomez De Liano, A., Morales-Barrera, R., Vuky, J., Pili, R., Hois, S., Boulos, S., Drakaki, A.
Published in European urology open science (Online) (01.11.2022)
Published in European urology open science (Online) (01.11.2022)
Get full text
Journal Article
Abstract P2-09-03: Updated efficacy of first or second-line pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC) and correlations with baseline lymphocyte and naïve CD4+ T-cell count
Page, DB, Pucilowska, J, Bennetts, L, Kim, I, Sanchez, K, Martel, M, Conlin, A, Moxon, N, Mellinger, S, Acheson, A, Kemmer, K, Mitri, Z, Vuky, J, Ahn, J, Abaya, C, Manigault, T, Basho, R, Urba, WJ, McArthur, HL
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Pembrolizumab (pembro) as first-line therapy in cisplatin-ineligible advanced urothelial cancer (UC): Outcomes from KEYNOTE-052 in senior patients (pts) with poor performance status
Grivas, P., Plimack, E., Balar, A.V., Castellano, D., O'Donnell, P.H., Bellmunt, J., Powles, T., Hahn, N., de Wit, R., Bajorin, D., Ellison, M.C., Frenkl, T., Keefe, S.M., Vuky, J.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Phase II study of everolimus (E) with imatinib (IM) in patients with previously-treated renal carcinoma (RCC)
Ryan, C. W., Vuky, J., Chan, J. S., Beer, T. M., Rothkopf, M.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Propofol anesthesia and rational opioid selection : Determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness
VUYK, J, MERTENS, M. J, OLOFSEN, E, BURM, A. G. L, BOVILL, J. G
Published in Anesthesiology (Philadelphia) (01.12.1997)
Published in Anesthesiology (Philadelphia) (01.12.1997)
Get full text
Journal Article
The evaluation of flaxseed for hot flashes: Results of a randomized, controlled trial, NCCTG study N08C7
Pruthi, S., Qin, R., Terstriep, S. A., Liu, H., Loprinzi, C. L., Shah, T. R. C., Tucker, K. F., Dakhil, S. R., Bury, M. J., Carolla, R. L., Steen, P. D., Vuky, J., Barton, D. L.
Published in Journal of clinical oncology (20.06.2011)
Published in Journal of clinical oncology (20.06.2011)
Get full text
Journal Article